These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 16838182)
21. Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography. Imai A; Komatsu S; Ohara T; Kamata T; Yoshida J; Miyaji K; Shimizu Y; Takewa M; Hirayama A; Deshpande GA; Takahashi O; Kodama K Atherosclerosis; 2011 Oct; 218(2):350-5. PubMed ID: 21782177 [TBL] [Abstract][Full Text] [Related]
22. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study). Patel D; Ahmad S; Silverman A; Lindsay J Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273 [TBL] [Abstract][Full Text] [Related]
23. Plasma cystatin C as a marker of renal function in patients with liver cirrhosis. Randers E; Ivarsen P; Erlandsen EJ; Hansen EF; Aagaard NK; Bendtsen F; Vilstrup H Scand J Clin Lab Invest; 2002; 62(2):129-34. PubMed ID: 12004928 [TBL] [Abstract][Full Text] [Related]
24. Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Hoke M; Amighi J; Mlekusch W; Schlager O; Exner M; Sabeti S; Dick P; Koppensteiner R; Minar E; Rumpold H; Wagner O; Schillinger M Stroke; 2010 Apr; 41(4):674-9. PubMed ID: 20150544 [TBL] [Abstract][Full Text] [Related]
25. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933 [TBL] [Abstract][Full Text] [Related]
26. Cystatin C--a marker of peripheral atherosclerotic disease? Arpegård J; Ostergren J; de Faire U; Hansson LO; Svensson P Atherosclerosis; 2008 Aug; 199(2):397-401. PubMed ID: 18187137 [TBL] [Abstract][Full Text] [Related]
27. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Knight EL; Verhave JC; Spiegelman D; Hillege HL; de Zeeuw D; Curhan GC; de Jong PE Kidney Int; 2004 Apr; 65(4):1416-21. PubMed ID: 15086483 [TBL] [Abstract][Full Text] [Related]
28. Serum cystatin C is associated with other cardiovascular risk markers and cardiovascular disease in elderly men. Larsson A; Helmersson J; Hansson LO; Basu S Int J Cardiol; 2008 Apr; 125(2):263-4. PubMed ID: 17996317 [TBL] [Abstract][Full Text] [Related]
29. [Cystatin C: current step and future prospects]. Séronie-Vivien S; Delanaye P; Pieroni L; Mariat C; Froissart M; Cristol JP; Ann Biol Clin (Paris); 2008; 66(3):301-23. PubMed ID: 18558570 [TBL] [Abstract][Full Text] [Related]
30. [Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?]. Font R; Prats M; Gutiérrez C; Bardají A; Lalana M; Marsillach J; Camps J; Martínez Vea A Nefrologia; 2009; 29(3):228-35. PubMed ID: 19554056 [TBL] [Abstract][Full Text] [Related]
31. Serum cystatin C as a marker of glomerular filtration rate. Madero M; Sarnak MJ; Stevens LA Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):610-6. PubMed ID: 17053476 [TBL] [Abstract][Full Text] [Related]
32. Chronic kidney disease: effects on the cardiovascular system. Schiffrin EL; Lipman ML; Mann JF Circulation; 2007 Jul; 116(1):85-97. PubMed ID: 17606856 [TBL] [Abstract][Full Text] [Related]
33. Cystatin-C and inflammatory markers in the ambulatory elderly. Shlipak MG; Katz R; Cushman M; Sarnak MJ; Stehman-Breen C; Psaty BM; Siscovick D; Tracy RP; Newman A; Fried L Am J Med; 2005 Dec; 118(12):1416. PubMed ID: 16378798 [TBL] [Abstract][Full Text] [Related]
34. Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults. Rodondi N; Yerly P; Gabriel A; Riesen WF; Burnier M; Paccaud F; Bovet P Nephrol Dial Transplant; 2007 Apr; 22(4):1107-14. PubMed ID: 17205961 [TBL] [Abstract][Full Text] [Related]
35. Increased serum cystatin C is associated with increased mortality in elderly men. Larsson A; Helmersson J; Hansson LO; Basu S Scand J Clin Lab Invest; 2005; 65(4):301-5. PubMed ID: 16076685 [TBL] [Abstract][Full Text] [Related]
36. Cystatin C and cathepsins in cardiovascular disease. Bengtsson E; Nilsson J; Jovinge S Front Biosci; 2008 May; 13():5780-6. PubMed ID: 18508621 [TBL] [Abstract][Full Text] [Related]
37. Mild renal dysfunction as a non-traditional cardiovascular risk factor?-Association of cystatin C-based glomerular filtration rate with flow-mediated vasodilation. Reffelmann T; Krebs A; Ittermann T; Empen K; Hummel A; Dörr M; Völzke H; Felix SB Atherosclerosis; 2010 Aug; 211(2):660-6. PubMed ID: 20399428 [TBL] [Abstract][Full Text] [Related]
38. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Dharnidharka VR; Kwon C; Stevens G Am J Kidney Dis; 2002 Aug; 40(2):221-6. PubMed ID: 12148093 [TBL] [Abstract][Full Text] [Related]
39. Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function. Meng L; Yang Y; Qi LT; Wang XJ; Xu GB; Zhang BW J Nephrol; 2012; 25(3):426-30. PubMed ID: 21928225 [TBL] [Abstract][Full Text] [Related]
40. How to use… serum creatinine, cystatin C and GFR. Pasala S; Carmody JB Arch Dis Child Educ Pract Ed; 2017 Feb; 102(1):37-43. PubMed ID: 27647862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]